Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1991 Oct;81(10):1273–1279. doi: 10.2105/ajph.81.10.1273

Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence.

J E Siegel 1, M C Weinstein 1, H V Fineberg 1
PMCID: PMC1405310  PMID: 1928525

Abstract

BACKGROUND. The growing importance of drug use as a mode of HIV transmission has led to increased attention to AIDS prevention among intravenous drug users (IVDUs). This analysis examines the effectiveness of bleach distribution, a program to prevent HIV transmission via shared needles. METHODS. We used a Markov model to assess the role of the initial HIV prevalence among drug users in determining the effectiveness of bleach programs. The model incorporates survey data on risk behaviors and published information describing HIV incubation and mortality. It predicts life expectancy for cohorts of IVDUs with and without a bleach program to estimate program effectiveness. RESULTS. We found that bleach programs can produce the greatest life-year savings in areas of low HIV prevalence. In the lowest prevalence scenario (0.02 initial prevalence), initiation of the program resulted in a projected savings of 2.3 life years per HIV-negative drug user, compared with 1.7 and 1.3 years under medium (0.25) and high (0.60) prevalence, respectively. CONCLUSIONS. While bleach programs are beneficial in all groups of IVDUs, these results highlight the advantages of introducing bleach programs early, when prevalence is still comparatively low in a drug-user population.

Full text

PDF
1273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allard R. A family of mathematical models to describe the risk of infection by a sexually transmitted agent. Epidemiology. 1990 Jan;1(1):30–33. doi: 10.1097/00001648-199001000-00007. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. M. Mathematical and statistical studies of the epidemiology of HIV. AIDS. 1989 Jun;3(6):333–346. doi: 10.1097/00002030-198906000-00001. [DOI] [PubMed] [Google Scholar]
  3. Beck J. R., Pauker S. G. The Markov process in medical prognosis. Med Decis Making. 1983;3(4):419–458. doi: 10.1177/0272989X8300300403. [DOI] [PubMed] [Google Scholar]
  4. Chaisson R. E., Moss A. R., Onishi R., Osmond D., Carlson J. R. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health. 1987 Feb;77(2):169–172. doi: 10.2105/ajph.77.2.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chaisson R. E., Osmond D., Moss A. R., Feldman H. W., Bernacki P. HIV, bleach, and needle sharing. Lancet. 1987 Jun 20;1(8547):1430–1430. doi: 10.1016/s0140-6736(87)90615-5. [DOI] [PubMed] [Google Scholar]
  6. De Gruttola V., Lagakos S. W. The value of AIDS incidence data in assessing the spread of HIV infection. Stat Med. 1989 Jan;8(1):35–43. doi: 10.1002/sim.4780080106. [DOI] [PubMed] [Google Scholar]
  7. De Gruttola V., Mayer K. H. Assessing and modeling heterosexual spread of the human immunodeficiency virus in the United States. Rev Infect Dis. 1988 Jan-Feb;10(1):138–150. doi: 10.1093/clinids/10.1.138. [DOI] [PubMed] [Google Scholar]
  8. Des Jarlais D. C., Friedman S. R., Stoneburner R. L. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis. 1988 Jan-Feb;10(1):151–158. doi: 10.1093/clinids/10.1.151. [DOI] [PubMed] [Google Scholar]
  9. Fineberg H. V. Education to prevent AIDS: prospects and obstacles. Science. 1988 Feb 5;239(4840):592–596. doi: 10.1126/science.3340845. [DOI] [PubMed] [Google Scholar]
  10. Friedland G. H., Klein R. S. Transmission of the human immunodeficiency virus. N Engl J Med. 1987 Oct 29;317(18):1125–1135. doi: 10.1056/NEJM198710293171806. [DOI] [PubMed] [Google Scholar]
  11. Froner G. A., Rutherford G. W., Rokeach M. Injection of sodium hypochlorite by intravenous drug users. JAMA. 1987 Jul 17;258(3):325–325. doi: 10.1001/jama.258.3.325. [DOI] [PubMed] [Google Scholar]
  12. Froner G. Disinfection of hypodermic syringes by i.v. drug users. AIDS. 1987 Jul;1(2):133–134. [PubMed] [Google Scholar]
  13. Harris J. E. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA. 1990 Jan 19;263(3):397–401. [PubMed] [Google Scholar]
  14. Kaplan E. H. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis. 1989 Mar-Apr;11(2):289–298. doi: 10.1093/clinids/11.2.289. [DOI] [PubMed] [Google Scholar]
  15. Lagakos S. W., De Gruttola V. The conditional latency distribution of AIDS for persons infected by blood transfusion. J Acquir Immune Defic Syndr. 1989;2(1):84–87. [PubMed] [Google Scholar]
  16. Marmor M., Des Jarlais D. C., Cohen H., Friedman S. R., Beatrice S. T., Dubin N., el-Sadr W., Mildvan D., Yancovitz S., Mathur U. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987 May;1(1):39–44. [PubMed] [Google Scholar]
  17. May R. M., Anderson R. M. Transmission dynamics of HIV infection. Nature. 1987 Mar 12;326(6109):137–142. doi: 10.1038/326137a0. [DOI] [PubMed] [Google Scholar]
  18. Newmeyer J. A. Why bleach? Fighting AIDS contagion among intravenous drug users: the San Francisco experience. J Psychoactive Drugs. 1988 Apr-Jun;20(2):159–163. doi: 10.1080/02791072.1988.10524488. [DOI] [PubMed] [Google Scholar]
  19. Rothenberg R., Woelfel M., Stoneburner R., Milberg J., Parker R., Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med. 1987 Nov 19;317(21):1297–1302. doi: 10.1056/NEJM198711193172101. [DOI] [PubMed] [Google Scholar]
  20. Schoenbaum E. E., Hartel D., Selwyn P. A., Klein R. S., Davenny K., Rogers M., Feiner C., Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989 Sep 28;321(13):874–879. doi: 10.1056/NEJM198909283211306. [DOI] [PubMed] [Google Scholar]
  21. Stoneburner R. L., Des Jarlais D. C., Benezra D., Gorelkin L., Sotheran J. L., Friedman S. R., Schultz S., Marmor M., Mildvan D., Maslansky R. A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science. 1988 Nov 11;242(4880):916–919. doi: 10.1126/science.3187532. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES